1.Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
Chinese Medical Journal 2019;132(23):2848-2855
Objective: In recent years,an increasing number of drugs have been proved to be associated with the induction of anti-neutrophil cytoplasmic antibody(ANCA)-associated vasculitis(AAV).This article reviews the latest research progress on drug-induced AAV.Data sources: We conducted a comprehensive and detailed search of the PubMed database.The search terms mainly included drug-induced,ANCA,and vasculitis.Study selection: We summarized the original articles and reviews on drug-induced AAV in recent years.The extracted information included the definition,epidemiology,associated drugs,pathogenesis,clinical features,diagnosis,treatment,and prognosis of drug-induced AAV.We also focused on the differences between drug-induced AAV and primary vasculitis.Results: The offending drugs leading to drug-induced AAV are almost from pharmacologic categories and we need to be vigilant when using these drugs.The pathogenesis of drug-induced AAV might be multifactorial.The formation of neutrophil extracellular traps is an important mechanism for the development of drug-induced AAV.The clinical features of drug-induced AAV are similar to those of primary AAV.Understanding the difference between drug-induced AAV and primary AAV is helpful to identify drug-induced AAV.Stopping the offending drug at once after diagnosis may be sufficient for those patients with mild symptoms.Immunosuppressive therapy should only be used in patients with vital organs involvement.Conclusions: Patients with drug-induced AAV usually have a good prognosis if they stop using the offending drug immediately.Recent advances in research on AAV are expected to help us better understand the pathogenesis of drug-induced AAV.
2.Study of RET proto-oncogene mutations in two pedigrees affected with multiple endocrine neoplasia type 2A.
Yu WENG ; Feng LI ; Shaoling ZHANG ; Hua CHENG ; Li YAN
Chinese Journal of Medical Genetics 2018;35(5):648-652
OBJECTIVETo study the pattern of RET proto-oncogene mutations in two pedigrees affected with multiple endocrine neoplasia type 2A (MEN2A).
METHODSPeripheral blood samples were collected from members of the two pedigrees, with total genomic DNA extracted for polymerase chain reaction (PCR). PCR products of 7 exons of the RET proto-oncogene (including exons 8, 10, 11, 13, 14, 15, 16) which have higher mutation rates were purified and subjected to direct sequencing. Suspected mutations in the 2 probands were verified in other members of the pedigrees. To exclude other mutations, PCR products of remaining 14 exons were sequenced in the proband from pedigree 1.
RESULTSA novel heterozygous mutation, 1893-1895delCGA, was detected in exon 11 of the RET proto-oncogene among 3 patients and 2 unaffected members from pedigree 1, while a heterozygous mutation, Cys634Arg, was detected in exon 11 among 2 patients and 1 unaffected family member from pedigree 2.
CONCLUSIONThe heterozygous 1893-1895delCGA and Cys634Arg mutations of the RET proto-oncogene probably underlie the disease in the two pedigrees. Above discovery has enriched the human gene mutation database.
3.A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations
Yu WENG ; Shengneng XUE ; Shaoling ZHANG ; Hua CHENG ; Li YAN
Chinese Journal of Internal Medicine 2018;57(2):134-137
Multiple endocrine neoplasia type 2A (MEN2A) is a hereditary syndrome. Here, two different RET proto-oncogen mutation were identified from family members of two MEN2A pedigrees by genetic screening. One RET mutations were found at codons 1893 and 1895 in exon 11 (1893-1895delCGA) from pedigree 1, which is a novel mutation, the other occurs at codon 634 (Cys634Arg) in exon 11 from pedigree 2. However, the clinical characteristics were similar in the patients of the two pedigrees. All the patients were in middle-age at onset. Most of them were firstly diagnosed with bilateral adrenal pheochromocytoma with different degrees of thyroid abnormalities (elevated serum calcitonin with or without thyroid mass, or had been diagnosed with medullary thyroid carcinoma). Some family members were with elevated serum parathyroid hormone but with no other evidences for hyperparathyroidism.
4.Predictors for Efficacy of Combination Therapy with a Nucleos(t)ide Analogue and Interferon for Chronic Hepatitis B
LI HONG ; WANG HUA ; PENG CHENG ; ZHENG XIN ; LIU JIA ; WENG ZHI-HONG ; YANG DONG-LIANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2017;37(4):547-555
This study aims to explore the efficacy of interferon-α (IFN-α) combined with either entecavir (ETV) or adefovir (ADV) therapy versus IFN-α mono-therapy for chronic hepatitis B (CHB) patients,and to identify the factors associated with treatment outcomes.Totally,159 CHB patients receiving interferon-based treatment for 48 weeks were enrolled in this retrospective study,including IFN-α mono-therapy group (group A,n=44),IFN-α plus ADV group (group B,n=53) and IFN-α plus ETV group (group C,n=62).The primary measures of efficacy assessments were the changes in HBsAg.Cox regression analysis was used to identify the predictors of treatment outcomes.The predictive values of the factors were assessed by ROC analysis.For patients with baseline hepatitis B surface antigen (HBsAg) level <1000 IU/mL,the reductions in mean HBsAg levels at week 48 were greater in group C than that in group A (P<0.05).Higher rate of HBeAg seroconversion was achieved in the combined therapy group than in IFN-α mono-therapy group at week 48 (P<0.05).Two factors were independently associated with HBeAg seroconversion:baseline HBeAg level <2.215 log10 index/mL and △HBeAg (.decline in HBeAg from baseline) >0.175 log10 at week 12.In conclusion,interferon-α plus ETV therapy can accelerate HBsAg decline as compared with interferon-α mono-therapy in CHB patients with lower baseline HBsAg levels,and the combination therapy was superior to IFN-α mono-therapy in increasing the rate of HBeAg seroconversion.Baseline HBeAg and △HBeAg at week 12 can independently predict HBeAg seroconversion in patients subject to interferon-based therapy for 48 weeks.
5.Evaluation of the effects of standard rescue procedure on severe trauma treatment in china.
Xiao-Feng YIN ; Tian-Bing WANG ; Pei-Xun ZHANG ; Yu-Hui KOU ; Dian-Ying ZHANG ; Kai YU ; De-Cheng LYU ; Mao-Zheng LIU ; Dong-Sheng ZHOU ; Peng ZHANG ; Jue-Hua JING ; Wei-Wei GE ; Li Ying CAO ; Guo-Sheng WANG ; Shao-Jie DENG ; Weng-Hua LIU ; Mao ZHANG ; Yong-An XU ; Kun ZHANG ; Bing LI ; Wei WANG ; Zhong-Li GAO ; Cheng-La YI ; Bao-Guo JIANG ;
Chinese Medical Journal 2015;128(10):1301-1305
BACKGROUNDThis study aimed to evaluate the effects of standard rescue procedure (SRP) in improving severe trauma treatments in China.
METHODSThis study was conducted in 12 hospitals located in geographically and industrially different cities in China. A standard procedure on severe trauma rescue was established as a general rule for staff training and patient treatment. A regional network (system) efficiently integrating prehospital rescue, emergency room treatments, and hospital specialist treatments was built under the rule for information sharing and improving severe trauma treatments. Treatment outcomes were compared between before and 1 year after the implementation of the SRP.
RESULTSThe outcomes of a total of 74,615 and 12,051 trauma cases were collected from 12 hospitals before and after the implementation of the SRP. Implementation of the SRP led to efficient cooperation and information sharing of different treatment services. The emergency response time, prehospital transit time, emergency rescue time, consultation call time, and mortality rate of patients were 24.24 ± 4.32 min, 45.69 ± 3.89 min, 6.38 ± 1.05 min, 17.53 ± 0.72 min, and 33.82% ± 3.87% (n = 441), respectively, before the implementation of the standardization and significantly reduced to 10.11 ± 3.21 min, 22.39 ± 4.32 min, 3.26 ± 0.89 min, 3.45 ± 0.45 min, and 20.49% ± 3.11%, separately (n = 495, P < 0.05) after that.
CONCLUSIONSStaff training and SRP can significantly improve the efficiency of severe trauma treatments in China.
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; China ; Emergency Medical Services ; standards ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Wounds and Injuries ; Young Adult
6.Characteristics of complete genome of pandemic A/H1N1/2009 influenza virus isolated in Fujian Province, China.
Jian-Feng XIE ; Xiao-Na SHEN ; Mei-Ai WANG ; Shi-Qin YANG ; Meng HUANG ; Yan-Hua ZHANG ; Wen-Qiong XIU ; Yu-Wei WENG ; Yan-Sheng YAN ; Kui-Cheng ZHENG
Chinese Journal of Virology 2014;30(1):37-43
This study aims to investigate the characteristics of genomic variation of pandemic A/H1N1/2009 influenza virus isolated in Fujian Province, China. Complete genome sequence analysis was performed on 14 strains of pandemic A/H1N1/2009 influenza virus isolated from Fujian during 2009-2012. All virus strains were typical low-pathogenic influenza viruses, with resistance to amantadine and sensitivity to neuraminidase inhibitors. Eight genome fragments of all strains were closely related to those of A/California/07/2009 (H1N1) vaccine strain, with > or = 98.2% homology. Compared with the vaccine strain, the influenza strains from Fujian had relatively large variation, and variation was identified at 11 amino acid sites of the HA gene of A/Fujiangulou/SWL1155/2012 strain, including 4 sites (H138R, L161I, S185T, and S203T) involved inthree antigen determinants (Ca, Sa, and Sb). In conclusion, the influenza vaccine has a satisfactory protective effect on Fujian population, but the influenza strains from Fujian in 2012 has antigenic drift compared with the vaccine strain, more attention should therefore be paid to the surveillance of mutations of pandemic A/H1N1/2009 influenza virus.
Antiviral Agents
;
pharmacology
;
China
;
epidemiology
;
Drug Resistance, Viral
;
genetics
;
Genome, Viral
;
genetics
;
Genomics
;
Humans
;
Influenza A Virus, H1N1 Subtype
;
drug effects
;
genetics
;
immunology
;
physiology
;
Influenza, Human
;
epidemiology
;
prevention & control
;
Pandemics
;
prevention & control
;
Viral Vaccines
;
immunology
7.Liver histopathological features influencing HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B responding to Peg-IFN treatment.
Hua-dong YAN ; Fan-rong JIANG ; Cheng-liang ZHU ; Guo-sheng GAO ; Peng-jian WENG ; Ai-rong HU ; Chang-feng XU ; Yao-ren HU ; Ji-fang SHENG
Chinese Journal of Hepatology 2013;21(5):340-344
OBJECTIVETo investigate the therapeutic efficiency of antiviral treatment with pegylated-interferon (Peg-IFN) for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) and to explore whether liver histopathological features or other factors influence the HBeAg seroconversion treatment response.
METHODSEighty HBeAg-positive CHB patients with diagnosis confirmed by liver puncture were treated with Peg-IFN(2a or 2b)body weight dose, once weekly). At treatment week 48, the rate of HBeAg seroconversion was determined and used to analyze the influence of liver histopathological features (liver biopsy assessment of: inflammation, graded G0 to G4; fibrosis stage, graded S0 to S4), sex, age, differential levels (pre-treatment baseline vs. week 48 post-treatment) of serum alanine transferase (ALT), and HBV DNA, by binary logistic analysis.
RESULTSAt week 48, the overall rate of HBeAg seroconversion was 30.0%. The rate of HBeAg seroconversion gradually advanced with increased liver inflammation (X2 = 8.435, P = 0.015): 9.09% of the 22 patients with G1; 31.58% of the 38 patients with G2; 47.30% of the 19 patients with G3; the one patient with G4. In contrast, the rate of HBeAg seroconversion showed a much weaker association with liver fibrosis (X2 = 5.917, P = 0.116). Only baseline HBeAg level, and no other baseline index, was significantly different between the patients who achieved HBeAg seroconversion and those who did not. Liver inflammation and baseline HBeAg level were identified as influencing factors of HbeAg seroconversion in response to Peg-IFN treatment.
CONCLUSIONPeg-IFN therapy induces a higher rate of HBeAg seroconversion in HBeAg-positive CHB patients with severe liver inflammation; histological analysis of pre-treatment liver biopsies may help to identify patients most likely to benefit from the antiviral regimen.
Adult ; Antiviral Agents ; therapeutic use ; Female ; Hepatitis B e Antigens ; blood ; Hepatitis B, Chronic ; blood ; drug therapy ; pathology ; Humans ; Interferon-alpha ; therapeutic use ; Liver ; pathology ; Male ; Polyethylene Glycols ; therapeutic use ; Recombinant Proteins ; therapeutic use ; Serologic Tests
8.A novel RET proto-oncogene mutation in a pedigree of multiple endocrine neoplasia type 2A
Shaoling ZHANG ; Yu WENG ; Li YAN ; Xiaohua JIANG ; Feng LI ; Lihong CHEN ; Yan LI ; Hua CHENG
Chinese Journal of Endocrinology and Metabolism 2008;24(3):282-286
Objective To observe the clinical manifestation and the mode of RET proto-oncogene mutation in a pedigree of mutiple endocrine neoplasia type 2A (MEN2A). Methods Genomic DNA was extracted from the peripheral blood lymphocytes in 18 family members including 3 patients, then PCR was performed to amplify seven exons of the RET proto-oncogene, i. e. exon 8,10,11,13-16. The PCR products were directly sequenced to identify the RET mutation and then sequenced after subcloning to identify their heterozygosity. Results The male proband suffered from pheochromocytoma and medullary thyroid carcinoma since the age of 30; while his sibling sister was ill with pheochromocytoma, and his brother with medullary thyroid carcinoma. A novel heterozygous mutation, 1893-1895delCGA, was detected in exon 11 of the RET proto-oncogene in the 3 patients and the other 2 family members. Conclusion A novel heterozygous mutation of RET proto-oncogene, 1893-1895delCGA, seems to be the disease-causing mutation in the studied MEN2A family.
9.Clinical management of abdominal trauma.
Guo-en FANG ; Tian-hang LUO ; Cheng-hui DU ; Jian-wei BI ; Xu-chao XUE ; Guo WEI ; Zhao-zhang WENG ; Li-ye MA ; Ji-de HUA
Chinese Journal of Traumatology 2008;11(4):239-242
OBJECTIVETo improve the prognosis of patients with abdominal trauma.
METHODSBetween January 1993 and December 2005, 415 patients were enrolled in this research. The patients consisted of 347 males and 68 females with mean age of 36 years (ranging from 3-82 years). All abdominal traumas consisted of closed traumas (360 cases, 86.7%) and open traumas (55 cases, 13.3%).
RESULTSA total of 407 cases (98.1%) were fully recovered from trauma and the other 8 cases (1.9%) died of multiple injuries. The mean injury severity score (ISS) of all patients was 22 while the mean ISS of the patients who died in hospital was 42. Postoperative complications were seen in 9 patients such as infection of incisional wounds (6 cases), pancreatic fistula (2 cases) and intestinal fistula (1 case). All these postoperative complications were cured by the conservative treatment.
CONCLUSIONCareful case history inquisition and physical examination are the basic methods to diagnose abdominal trauma. Focused abdominal ultrasonography is always the initial imaging examination because it is non-invasive and can be performed repeatedly with high accuracy. The doctors should consider the severity of local injuries and the general status of patients during the assessment of abdominal trauma. The principle of treatment is to save lives at first, then to cure the injuries. Unnecessary laparotomy should be avoided to reduce additional surgical trauma.
Abdominal Injuries ; diagnosis ; therapy ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Humans ; Male ; Middle Aged
10.Study on food preference and dietary behavior to overweight/obesity in school children and adolescents in Guangzhou: a case-control study
Li-Hua XIONG ; Cui-Ling WANG ; Zong-Qiu CHEN ; Jian-Ping WENG ; Wei-Qing CHEN ; Jin-Cheng MAI ; Yu-Ming CHEN
Chinese Journal of Epidemiology 2008;29(10):965-969
Objective This study assessed the effect of food preference and dietary behaviors on the risk of overweight or obesity in school children and adolescents aged 6-19 years.Methods A11 overweight or obeoe students,with age-and school-matched controls were recruited for this case-control study from 28 elementary and secondary schools in Guangzhou urban districts from October 2006 to April 2007.Weight and height were measured,and body nlass index was calculated for the classification of obesity.overweight and underweight.Their food preference and behaviors were asesbed using a structured questionnaire completed by their parents.Behavior and food preference were classified into four levels.and the relevant bottom levels were defined as control groups.Logistic regression wfs used to assess independent determinants of overweight and obesity.Results Among 7136 participants,1947 cases and 2136 normal weight controls from 5755 students with valid questionnaire data were included in the study.Results from univariate analysis showed that odds ratios for overweight or obesity were 0.60-0.69 in those with moat preference(top group)on vegetables,fruits,candy,evening snacks,0.50 in the students of less food partiality,1.84,1.30 and 1.26 in those of most preference for pork,beef and deep-fried foods.and 5.14 in students with fastest speed during eating,respectively(all P<0.05).Vegetable intake,evening snacks preference,speed during eating and food partiality remained with significant agsociation with overweight and obesity in multivariate analysis after adjusted for age,sex,family socio-economical status and their parents' body build. The adjusted odds ratios (OR) and 95% confidence intervals (95% CI) of the above items became 0.55 (0.42-0.73), 0.48 (0.35-0.65), 0.50(0.39-0.65),and 4.32(3.23-5.80) as compared to the relevant lowest categories, respecively. Conclusion Behaviors as eating more vegetable and slow-eating might be protective factos against overweight and obesity in school clildren.

Result Analysis
Print
Save
E-mail